Drug Trial Radar · NCT06642272
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
Last checked: Nov 19, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
17,200
Planned (sponsor's estimate)
Start
Oct 10, 2024
Primary completion
Dec 31, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Herlev and Gentofte HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this clinical trial is investigate the comparative effectiveness of empagliflozin and dapagliflozin for the treatment of diabetes, chronic kidney disease, and heart failure. Patients who are prescribed either empagliflozin or dapagliflozin, as part of daily clinical practice at the participating sites, will be included in the study. Treatment will be randomized automatically through the electronic health record software in clusters defined by time of day. https://www.appletreestudy.com
Conditions
- Diabetes Mellitus, Type 2
- Heart Failure
- Chronic Kidney Diseases
Interventions
Empagliflozin 10 MGDrug
Once daily
Dapagliflozin 10 MGDrug
Once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to the first occurrence of any of the components of the composite: all-cause mortality, hospitalization for heart failure, hospitalization for myocardial infarction, hospitalization for ischemic stroke, and incident or worsening nephropathy.Time frame: Up to 24 months
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Bispebjerg Hospital
Copenhagen, Denmark · Recruiting
Rigshospitalet
Copenhagen, Denmark · Recruiting
Herlev and Gentofte Hospital
Herlev, Denmark · Recruiting
Steno Diabetes Center Copenhagen
Herlev, Denmark · Recruiting
Nordsjællands Hospital
Hillerød, Denmark · Recruiting
Holbæk Sygehus
Holbæk, Denmark · Recruiting
Hvidovre Hospital
Hvidovre, Denmark · Recruiting
Sjællands Universitetshospital
Køge, Denmark · Recruiting
Nykøbing F. Sygehus
Nykøbing Falster, Denmark · Recruiting
Bornholms Hospital
Rønne, Denmark · Recruiting
Sjællands Universitetshospital
Roskilde, Denmark · Recruiting
Slagelse Sygehus
Slagelse, Denmark · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.